Fundraising FoxResync
2 known investors
Find your way into Resync
Sign up to see every warm intro you have to Resync
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Resync team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ReSync Bio provided drug discovery teams with no-code access to AI tools for molecular design and analysis, removing the need to build their own infrastructure. The company has been acquired by Benchling and is sunsetting its platform.
Founders & leadership
M
Mihir
N
Nishanth
L
Lindsay
T
Tony
C
Chelsea
Investors · 2
Atria Ventureslisted by Atria VenturesSan Francisco · $500K – $3M
How we know: Atria Ventures's portfolio page · Not right? Tell us
Caffeinated CapitalreportedSan Francisco · $3M – $50M
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Resync do?
- ReSync Bio provided drug discovery teams with no-code access to AI tools for molecular design and analysis, removing the need to build their own infrastructure. The company has been acquired by Benchling and is sunsetting its platform.
- Who are Resync's investors?
- Resync's investors include Atria Ventures, Caffeinated Capital.